Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

Natural adsorbents in cosmetics can significantly reduce skin and hair pollution.

Certain probiotics can help improve skin conditions like atopic dermatitis, but more research is needed.

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Hair lipids do not protect against humidity.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Some herbal treatments are effective for skin disorders, but more research and regulation are needed.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The editorial concludes that while evidence-based medicine is crucial, doctors should also use their own experience and consider patient preferences in dermatology care.

People with hair loss often have lower levels of zinc and copper in their blood.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

About 69% of school children in Kashmir valley have skin disorders, with eczema and acne being the most common.

Topical corticosteroid was not more effective than placebo for children's alopecia areata, and atopy did not change treatment results.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Eating the right foods is important for skin health and can help treat some skin conditions.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

Topical corticosteroid treatment showed no significant difference from placebo in treating alopecia areata in children.

Zinc oxide nanoparticles in sunscreen do not penetrate deep into the skin.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.